Sernova Corp. (TSE:SVA – Get Free Report)’s stock price rose 2.5% on Monday . The company traded as high as C$0.21 and last traded at C$0.21. Approximately 30,701 shares were traded during trading, a decline of 78% from the average daily volume of 141,257 shares. The stock had previously closed at C$0.20.
Sernova Price Performance
The company has a market capitalization of C$68.98 million, a PE ratio of -1.98 and a beta of 1.35. The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of -4.40. The company’s 50 day moving average price is C$0.18 and its 200-day moving average price is C$0.22.
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Recommended Stories
- Five stocks we like better than Sernova
- Where to Find Earnings Call Transcripts
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- 3 Small Caps With Big Return Potential
- Why Call Option Traders Are Targeting This Dividend ETF Now
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
